Global Mineral-Based Adjuvants Market Size, Share and Trends Analysis Report, By Type (Aluminum Compounds, phosphate adjuvants and Calcium Phosphate Adjuvants), By Disease (Infectious Disease and Cancer) By Application (Human Vaccines and Veterinary Vaccines), Forecast Period (2022-2028)

The global mineral-based adjuvants market is anticipated to grow at a significant CAGR of 9.2% during the forecast period (2022-2028). Adjuvants like aluminum hydroxyphosphate sulfate, monophosphoryl lipid A (MPL) + aluminum salts, oil-based emulsions made from squalene, MPL, and -QS-21 (a natural compound from the Chilean soap tree incorporated in liposomal formulation), and cytosine phosphoguanine (CpG) are currently used in vaccines like DtaP (Daptacel, Infanrix), Furthermore, there has been an increase in interest in adjuvant technology for the development of the COVID-19 vaccine, and this trend is projected to continue the market growth experienced in the region during the timeframe. For instance, in March 2022 (Clover; HKEX: 2197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced positive clinical results from several studies evaluating Clover’s COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), including five-month follow-up efficacy and immune responses following a booster dose.

Over the forecast period, mineral salt-based adjuvants are expected to show a significant increase. In human vaccines, alum vaccine additives are the most extensively utilized adjuvants. Aluminum hydroxide, aluminum phosphate, and aluminum hydroxy phosphate are examples of aluminum salts. Aluminum-based salt is also employed in vaccination studies to improve vaccine efficacy. Calcium salts, iron, and zirconium, in addition to alum, are widely employed as alum salt substitutes. Diphtheria-tetanus-pertussis (DTP), polio, yellow fever, and BCG vaccines all include calcium phosphate. It promotes soluble antigens in the immune system and surreptitiously expresses them. According to a study published in 2020, the development of mineral salt-based adjuvants is continuing to improve the adjuvant activity of aluminum adjuvants, including the use of nano-aluminum additions to boost antigen.

Some major players in the market include ADJUVATIS, Clover Biopharmaceuticals, Ltd., GlaxoSmithKline plc. Merck KGaA, Novavax, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Disease Type
  • By Indication
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- ADJUVATIS, Clover Biopharmaceuticals, Ltd., GlaxoSmithKline plc. Merck KGaA, Novavax, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Mineral-Based Adjuvants Market Report by Segment

By Type

• Aluminum Compounds
• Calcium Phosphate Adjuvants
• Phosphate Adjuvants

By Disease Type

• Infectious Disease
• Cancer

By Application

• Human Vaccines
• Veterinary Vaccines

Global Mineral-Based Adjuvants Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa